Global Peripheral Arterial Disease (PAD) Drugs Market Research Report 2021
Exclusive deal : 20% Instant discount on Direct purchases! Don't wait—claim your discount today!
Research Predicts that Peripheral Arterial Disease (PAD) Drugs Market was valued USD xxxx unit in 2020 and is expected to reach USD xxxx Unit by the year 2025, growing at a CAGR of xx% globally.
Global Peripheral Arterial Disease (PAD) Drugs Market Overview:
Global Peripheral Arterial Disease (PAD) Drugs Market Report 2020 comes with the extensive industry analysis of development components, patterns, flows and sizes. The report also calculates present and past market values to forecast potential market management through the forecast period between 2020-2025.This research study of Peripheral Arterial Disease (PAD) Drugs involved the extensive usage of both primary and secondary data sources. This includes the study of various parameters affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry.
Impact of COVID-19 on Peripheral Arterial Disease (PAD) Drugs Market
Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost every country around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affected the Peripheral Arterial Disease (PAD) Drugs market in 2020.
Global Peripheral Arterial Disease (PAD) Drugs Market Segmentation
By Type, Peripheral Arterial Disease (PAD) Drugs market has been segmented into:
Clopidogrel (Plavix)
Prasugrel (Effient)
Ticagrelor (Brilinta)
Vorapaxar (Zontivity)
Others
By Application, Peripheral Arterial Disease (PAD) Drugs market has been segmented into:
Hospitals
Clinics
Others
Regional Analysis:
North America (U.S., Canada, Mexico)
Europe (Germany, U.K., France, Italy, Russia, Spain etc.)
Asia-Pacific (China, India, Japan, Southeast Asia etc.)
South America (Brazil, Argentina etc.)
Middle East & Africa (Saudi Arabia, South Africa etc.)
Top Key Players Covered in Peripheral Arterial Disease (PAD) Drugs market are:
AstraZeneca Plc. (UK)
Bayer HealthCare Pharmaceuticals (Germany)
Bristol-Myers Squibb Company (US)
Merck & Co. Inc. (US)
Proteon Therapeutics Inc. (US)
Sanofi S.A. (France)
Symic Bio Inc. (US)
TheraVasc Inc. (US)
1. Market Overview of Peripheral Arterial Disease (PAD) Drugs
1.1 Peripheral Arterial Disease (PAD) Drugs Market Overview
1.1.1 Peripheral Arterial Disease (PAD) Drugs Product Scope
1.1.2 Market Status and Outlook
1.2 Peripheral Arterial Disease (PAD) Drugs Market Size by Regions: 2015 VS 2021 VS 2026
1.3 Peripheral Arterial Disease (PAD) Drugs Historic Market Size by Regions (2015-2020)
1.4 Peripheral Arterial Disease (PAD) Drugs Forecasted Market Size by Regions (2021-2026)
1.5 Covid-19 Impact on Key Regions, Keyword Market Size YoY Growth (2015-2026)
1.5.1 North America
1.5.2 East Asia
1.5.3 Europe
1.5.4 South Asia
1.5.5 Southeast Asia
1.5.6 Middle East
1.5.7 Africa
1.5.8 Oceania
1.5.9 South America
1.5.10 Rest of the World
1.6 Coronavirus Disease 2019 (Covid-19) Impact Will Have a Severe Impact on Global Growth
1.6.1 Covid-19 Impact: Global GDP Growth, 2019, 2020 and 2021 Projections
1.6.2 Covid-19 Impact: Commodity Prices Indices
1.6.3 Covid-19 Impact: Global Major Government Policy
2. Covid-19 Impact Peripheral Arterial Disease (PAD) Drugs Sales Market by Type (2015-2026)
2.1 Global Peripheral Arterial Disease (PAD) Drugs Historic Market Size by Type (2015-2020)
2.2 Global Peripheral Arterial Disease (PAD) Drugs Forecasted Market Size by Type (2021-2026)
2.3 Clopidogrel (Plavix)
2.4 Prasugrel (Effient)
2.5 Ticagrelor (Brilinta)
2.6 Vorapaxar (Zontivity)
2.7 Others
3. Covid-19 Impact Peripheral Arterial Disease (PAD) Drugs Sales Market by Application (2015-2026)
3.1 Global Peripheral Arterial Disease (PAD) Drugs Historic Market Size by Application (2015-2020)
3.2 Global Peripheral Arterial Disease (PAD) Drugs Forecasted Market Size by Application (2021-2026)
3.3 Hospitals
3.4 Clinics
3.5 Others
4. Covid-19 Impact Market Competition by Manufacturers
4.1 Global Peripheral Arterial Disease (PAD) Drugs Production Capacity Market Share by Manufacturers (2015-2020)
4.2 Global Peripheral Arterial Disease (PAD) Drugs Revenue Market Share by Manufacturers (2015-2020)
4.3 Global Peripheral Arterial Disease (PAD) Drugs Average Price by Manufacturers (2015-2020)
5. Company Profiles and Key Figures in Peripheral Arterial Disease (PAD) Drugs Business
5.1 AstraZeneca Plc. (UK)
5.1.1 AstraZeneca Plc. (UK) Company Profile
5.1.2 AstraZeneca Plc. (UK) Peripheral Arterial Disease (PAD) Drugs Product Specification
5.1.3 AstraZeneca Plc. (UK) Peripheral Arterial Disease (PAD) Drugs Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.2 Bayer HealthCare Pharmaceuticals (Germany)
5.2.1 Bayer HealthCare Pharmaceuticals (Germany) Company Profile
5.2.2 Bayer HealthCare Pharmaceuticals (Germany) Peripheral Arterial Disease (PAD) Drugs Product Specification
5.2.3 Bayer HealthCare Pharmaceuticals (Germany) Peripheral Arterial Disease (PAD) Drugs Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.3 Bristol-Myers Squibb Company (US)
5.3.1 Bristol-Myers Squibb Company (US) Company Profile
5.3.2 Bristol-Myers Squibb Company (US) Peripheral Arterial Disease (PAD) Drugs Product Specification
5.3.3 Bristol-Myers Squibb Company (US) Peripheral Arterial Disease (PAD) Drugs Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.4 Merck & Co. Inc. (US)
5.4.1 Merck & Co. Inc. (US) Company Profile
5.4.2 Merck & Co. Inc. (US) Peripheral Arterial Disease (PAD) Drugs Product Specification
5.4.3 Merck & Co. Inc. (US) Peripheral Arterial Disease (PAD) Drugs Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.5 Proteon Therapeutics Inc. (US)
5.5.1 Proteon Therapeutics Inc. (US) Company Profile
5.5.2 Proteon Therapeutics Inc. (US) Peripheral Arterial Disease (PAD) Drugs Product Specification
5.5.3 Proteon Therapeutics Inc. (US) Peripheral Arterial Disease (PAD) Drugs Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.6 Sanofi S.A. (France)
5.6.1 Sanofi S.A. (France) Company Profile
5.6.2 Sanofi S.A. (France) Peripheral Arterial Disease (PAD) Drugs Product Specification
5.6.3 Sanofi S.A. (France) Peripheral Arterial Disease (PAD) Drugs Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.7 Symic Bio Inc. (US)
5.7.1 Symic Bio Inc. (US) Company Profile
5.7.2 Symic Bio Inc. (US) Peripheral Arterial Disease (PAD) Drugs Product Specification
5.7.3 Symic Bio Inc. (US) Peripheral Arterial Disease (PAD) Drugs Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.8 TheraVasc Inc. (US)
5.8.1 TheraVasc Inc. (US) Company Profile
5.8.2 TheraVasc Inc. (US) Peripheral Arterial Disease (PAD) Drugs Product Specification
5.8.3 TheraVasc Inc. (US) Peripheral Arterial Disease (PAD) Drugs Production Capacity, Revenue, Price and Gross Margin (2015-2020)
6. North America
6.1 North America Peripheral Arterial Disease (PAD) Drugs Market Size (2015-2026)
6.2 North America Peripheral Arterial Disease (PAD) Drugs Key Players in North America (2015-2020)
6.3 North America Peripheral Arterial Disease (PAD) Drugs Market Size by Type (2015-2020)
6.4 North America Peripheral Arterial Disease (PAD) Drugs Market Size by Application (2015-2020)
7. East Asia
7.1 East Asia Peripheral Arterial Disease (PAD) Drugs Market Size (2015-2026)
7.2 East Asia Peripheral Arterial Disease (PAD) Drugs Key Players in North America (2015-2020)
7.3 East Asia Peripheral Arterial Disease (PAD) Drugs Market Size by Type (2015-2020)
7.4 East Asia Peripheral Arterial Disease (PAD) Drugs Market Size by Application (2015-2020)
8. Europe
8.1 Europe Peripheral Arterial Disease (PAD) Drugs Market Size (2015-2026)
8.2 Europe Peripheral Arterial Disease (PAD) Drugs Key Players in North America (2015-2020)
8.3 Europe Peripheral Arterial Disease (PAD) Drugs Market Size by Type (2015-2020)
8.4 Europe Peripheral Arterial Disease (PAD) Drugs Market Size by Application (2015-2020)
9. South Asia
9.1 South Asia Peripheral Arterial Disease (PAD) Drugs Market Size (2015-2026)
9.2 South Asia Peripheral Arterial Disease (PAD) Drugs Key Players in North America (2015-2020)
9.3 South Asia Peripheral Arterial Disease (PAD) Drugs Market Size by Type (2015-2020)
9.4 South Asia Peripheral Arterial Disease (PAD) Drugs Market Size by Application (2015-2020)
10. Southeast Asia
10.1 Southeast Asia Peripheral Arterial Disease (PAD) Drugs Market Size (2015-2026)
10.2 Southeast Asia Peripheral Arterial Disease (PAD) Drugs Key Players in North America (2015-2020)
10.3 Southeast Asia Peripheral Arterial Disease (PAD) Drugs Market Size by Type (2015-2020)
10.4 Southeast Asia Peripheral Arterial Disease (PAD) Drugs Market Size by Application (2015-2020)
11. Middle East
11.1 Middle East Peripheral Arterial Disease (PAD) Drugs Market Size (2015-2026)
11.2 Middle East Peripheral Arterial Disease (PAD) Drugs Key Players in North America (2015-2020)
11.3 Middle East Peripheral Arterial Disease (PAD) Drugs Market Size by Type (2015-2020)
11.4 Middle East Peripheral Arterial Disease (PAD) Drugs Market Size by Application (2015-2020)
12. Africa
12.1 Africa Peripheral Arterial Disease (PAD) Drugs Market Size (2015-2026)
12.2 Africa Peripheral Arterial Disease (PAD) Drugs Key Players in North America (2015-2020)
12.3 Africa Peripheral Arterial Disease (PAD) Drugs Market Size by Type (2015-2020)
12.4 Africa Peripheral Arterial Disease (PAD) Drugs Market Size by Application (2015-2020)
13. Oceania
13.1 Oceania Peripheral Arterial Disease (PAD) Drugs Market Size (2015-2026)
13.2 Oceania Peripheral Arterial Disease (PAD) Drugs Key Players in North America (2015-2020)
13.3 Oceania Peripheral Arterial Disease (PAD) Drugs Market Size by Type (2015-2020)
13.4 Oceania Peripheral Arterial Disease (PAD) Drugs Market Size by Application (2015-2020)
14. South America
14.1 South America Peripheral Arterial Disease (PAD) Drugs Market Size (2015-2026)
14.2 South America Peripheral Arterial Disease (PAD) Drugs Key Players in North America (2015-2020)
14.3 South America Peripheral Arterial Disease (PAD) Drugs Market Size by Type (2015-2020)
14.4 South America Peripheral Arterial Disease (PAD) Drugs Market Size by Application (2015-2020)
15. Rest of the World
15.1 Rest of the World Peripheral Arterial Disease (PAD) Drugs Market Size (2015-2026)
15.2 Rest of the World Peripheral Arterial Disease (PAD) Drugs Key Players in North America (2015-2020)
15.3 Rest of the World Peripheral Arterial Disease (PAD) Drugs Market Size by Type (2015-2020)
15.4 Rest of the World Peripheral Arterial Disease (PAD) Drugs Market Size by Application (2015-2020)
16 Peripheral Arterial Disease (PAD) Drugs Market Dynamics
16.1 Covid-19 Impact Market Top Trends
16.2 Covid-19 Impact Market Drivers
16.3 Covid-19 Impact Market Challenges
16.4 Porter’s Five Forces Analysis
18 Regulatory Information
17 Analyst's Viewpoints/Conclusions
18 Appendix
18.1 Research Methodology
18.1.1 Methodology/Research Approach
18.1.2 Data Source
18.2 Disclaimer
Research Methodology:
Peripheral Arterial Disease (PAD) Drugs Market Size Estimation
To estimate market size and trends, we use a combination of top-down and bottom-up methods. This allows us to evaluate the market from various perspectives—by company, region, product type, and end users.
Our estimates are based on actual sales data, excluding any discounts. Segment breakdowns and market shares are calculated using weighted averages based on usage rates and average prices. Regional insights are determined by how widely a product or service is adopted in each area.
Key companies are identified through secondary sources like industry reports and company filings. We then verify revenue estimates and other key data points through primary research, including interviews with industry experts, company executives, and decision-makers.
We take into account all relevant factors that could influence the market and validate our findings with real-world input. Our final insights combine both qualitative and quantitative data to provide a well-rounded view. Please note, these estimates do not account for unexpected changes such as inflation, economic downturns, or policy shifts.
Data Source
Secondary Sources
This study draws on a wide range of secondary sources, including press releases, annual reports, non-profit organizations, industry associations, government agencies, and customs data. We also referred to reputable databases and directories such as Bloomberg, Wind Info, Hoovers, Factiva, Trading Economics, Statista, and others. Additional references include investor presentations, company filings (e.g., SEC), economic data, and documents from regulatory and industry bodies.
These sources were used to gather technical and market-focused insights, identify key players, analyze market segmentation and classification, and track major trends and developments across industries.
| Market Size |
|
|
| Market Position of Top Company |
|
|
| Qualitative Analysis |
|
|
Primary Sources
As part of our primary research, we interviewed a variety of stakeholders from both the supply and demand sides to gather valuable qualitative and quantitative insights.
On the supply side, we spoke with product manufacturers, competitors, industry experts, research institutions, distributors, traders, and raw material suppliers. On the demand side, we engaged with business leaders, marketing and sales heads, technology and innovation directors, supply chain executives, and end users across key organizations.
These conversations helped us better understand market segmentation, pricing, applications, leading players, supply chains, demand trends, industry outlook, and key market dynamics—including risks, opportunities, barriers, and strategic developments.
Key Data Information from Primary Sources
| Primary Sources | Parameters | Key Data |
| Market Segments(by Application, by Type) |
|
|
| Total Market |
|
|